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Abstract: Health systems research and development is
needed to support the global malaria eradication agenda.
In this paper, we (the malERA Consultative Group on
Health Systems and Operational Research) focus on the
health systems needs of the elimination phase of malaria
eradication and consider groupings of countries at
different stages along the pathway to elimination. We
examine the difference between the last attempt at
eradication of malaria and more recent initiatives, and
consider the changing health system challenges as
countries make progress towards elimination. We review
recent technological and theoretical developments relat-
ed to health systems and the renewed commitment to
strengthening health systems for universal access and
greater equity. Finally, we identify a number of needs for
research and development, including tools for analyzing
and improving effective coverage and strengthening
decision making and discuss the relevance of these needs
at all levels of the health system from the community to
the international level.
Introduction
The last attempt at (global) eradication of malaria, which lasted
from 1955 to approximately 1969, depended on vertical
operations (centrally organized activities not linked to subnational
administrative levels and/or communities). These operations—
largely indoor residual spraying—often bypassed health systems,
because it was assumed that they could be run most efficiently with
minimal collaboration with general health services, which were
often poorly developed in endemic areas. In the later phases of the
first eradication era, it became clear that some form of
chemotherapy was needed to reduce transmission, and that good
surveillance was essential for achieving and maintaining malaria-
free status in a given area. Increased attention was then given to
integration with existing health services and to using malaria
eradication strategically to build rudimentary health services in
remote areas [1,2].
Here, we examine the health systems research and development
that is necessary to support a global malaria eradication agenda.
We do not address broader macroeconomic and health system
development needs, even though addressing them would be
beneficial to all agendas. We focus on the elimination phase of the
eradication agenda and considers groupings of countries at
different stages along the pathway to elimination.
On the basis of previous experiences with malaria and other
diseases for which eradication has been attempted, we use
standard definitions for control, elimination, and eradication
throughout this article (Box 1) [3]. Importantly, these definitions
emphasize the need for continued interventions for both malaria
control and elimination.
The Health System
In 2000, The World Health Organization (WHO) articulated a
comprehensive definition of health systems that is now widely
adopted. A health system ‘‘consists of all organizations, people and
actions whose primary intent is to promote, restore or maintain
health’’ [4] with goals of ‘‘improving health and health equity in
ways that are responsive, financially fair and make the best, or
most efficient, use of available resources.’’ In 2007, WHO
developed a conceptual framework comprising six ‘‘health system
building blocks’’ that has also been widely adopted (Box 2) [5].
This framework has now been further elaborated [6] to include
the role of people, not just at the centre of the system as mediators
and beneficiaries, but as key actors in driving the system itself.
Thus, the framework includes the participation of people as
individuals and in civil society organizations and stakeholder
networks, which influence each of the building blocks. Placing
people and their institutions at the centre of this framework
emphasizes WHO’s renewed commitment to the principles and
values of primary health care—fairness, social justice, participa-
tion, and intersectoral collaboration (see Figure 1).
Currently,three revolutions are underwaythat will transform health
systems: the biotechnology revolution, the communications and
information technology revolution, and the systems thinking. Systems
thinking is a holistic approach to analysis that focuses on the emergent
behaviour of complex systems. It analyzes how a system’s constituent
parts interrelate and how systems work over time and within the
context of larger systems. Applied to problem solving, systems thinking
addresses the dynamic, mainly nonlinear linkages, interactions, and
behaviours among the elements of the entire system. Systems thinking
as developed and used for other complex systems is now being applied
in health systems [7] and is essential for understanding what works, for
whom, to what extent, and under what circumstances. It also helps
predict and mitigate possible unintended consequences of particular
actions and to exploit synergies from concerted action in the system.
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as the malaria eradication agenda develops.
Health Systems for Malaria Control, Elimination,
and Eradication
The Global Malaria Action Plan(GMAP)waslaunched in 2008by
the Roll Back Malaria partnership against a background of greatly
increased investment in research and development for malaria-
control technologies since 1999 and extraordinary increases in
funding for malaria control through national and global financing
mechanisms since 2002 [8]. The GMAP includes three phases. The
first phase—scaling-up for impact—aims to rapidly reach universal
coverage for all populations at risk with locally appropriate malaria-
control interventions, supported by strengthened health systems. The
second phase—sustained control—aims to prevent the resurgence of
malaria by maintaining universal intervention coverage until
countries enter the elimination stage. In the final phase—elimination
and eradication—it is estimated that more than 20 lower burden
countries around the world will be poised to eliminate malaria.
There is currently a broad global consensus on malaria-control
strategies, and almost all malaria-endemic countries now have
national malaria programmes in line with GMAP. Malaria
indicators (both for coverage and health impact) are moving in
the right direction in many countries [9]. However, progress in
most endemic countries is slower than it could be, given the
available financial resources. Among the main reasons for the
suboptimal pace are constraints to the delivery of essential malaria
interventions at effective coverage levels and quality to populations
in need [9–11]. There is no doubt that success in moving towards
eradication will be heavily dependent on health systems [12,13].
Some of the health system challenges in a country facing a huge
malaria burden and in a country on the brink of phasing out the
disease are similar, but such countries also pose different health
system challenges. For example, quality case management is
needed in all phases. In contrast to most other diseases for which
elimination is being considered, the symptoms of malaria are
nonspecific. Furthermore, treatment needs to start soon after
symptoms appear both to prevent the development of severe
disease and death and, particularly in areas where malaria
prevalence is low, to help reduce transmission. The capacity to
diagnose and provide early and effective treatment is therefore
needed wherever there is a malaria risk. Achieving this capacity
requires quality coverage of general health services and is an
important systemic challenge for any antimalaria programme.
By contrast, although survey data can be useful for gauging
progress in highly endemic areas, disease surveillance becomes
increasingly important as the disease burden is lowered. Highly
sensitive and dynamic surveillance becomes the crucial element in
the pre-elimination phase and after [14]. Again, this capacity can
only be achieved by a solid articulation between a specialized
programme and functional general health services.
Finally, although the integration (or at least coordination) of
malaria vector control and other preventive interventions with other
health programmes can be synergistic and efficient in many settings,
such integration becomes less efficient as progress makes malaria an
increasingly focal and epidemic disease. Thus, malaria preventive
interventions can sometimes be managed independently from general
Box 1. Definitions of Control, Elimination, and
Related Concepts [3]
Control: Reduction of disease incidence, prevalence, mor-
bidity, or mortality to a locally acceptable level as a result of
deliberate efforts; continued intervention measures are
required to maintain control.
Elimination of disease: Reduction to zero of the incidence of
a specified disease in a defined geographic area as a result
of deliberate efforts; continued intervention measures are
required.
Elimination of infection: Reduction to zero of the incidenceof
infection caused by a specific agent in a defined geographic
area as a result of deliberate efforts; continued measures to
prevent reestablishment are required.
Eradication: Permanent reduction to zero of the worldwide
incidence of infection caused by a specific agent as a result
of deliberate efforts; intervention measures are no longer
needed.
Extinction: The specific infectious agent no longer exists in
nature or the laboratory.
Box 2. The Six Health System Building Blocks
[5]
N Governance: (including leadership) ensuring strategic
policy frameworks combined with effective oversight,
coalition building, accountability, transparency, regula-
tions, incentives, and attention to system design
N Health workforce: responsive, fair, and efficient given
available resources and circumstances, and available in
sufficient numbers
N Health financing: raising adequate funds for health in
ways that ensure people can use needed services and
are protected from financial catastrophe or impoverish-
ment associated with having to pay for them
N Health technologies: including medical products,
vaccines, diagnostics, and other technologies of assured
quality, safety, efficacy, and cost-effectiveness
N Health information: ensuring the production, analysis,
dissemination, and use of reliable and timely information
on health determinants, health systems performance,
and health status
N Service delivery: including effective, safe, and quality
personal and nonpersonal health interventions that are
provided to those in need, when and where needed
(including infrastructure), with a minimal waste of
resources
Figure 1. Health system building blocks [7]. Image credit: Fusio ´n
Creativa.
doi:10.1371/journal.pmed.1000397.g001
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fundamental health system elements such as policy and governance,
human resources, financing, supplies, and monitoring.
Much progress has been made in recent years towards
understanding health systems better and the importance of
strengthening them. The result is that global health initiatives are
providing increased funding for national health systems to
accelerate progress on universal access to essential health
interventions, including malaria interventions. New initiatives
such as the Task Force on Innovative Financing for Health
Systems [15], and initiatives from the Global Fund to Fight Aids,
Tuberculosis and Malaria (GFATM), Global Alliance for
Vaccines and Immunization (GAVI), WHO, World Bank Joint
Platform for Health Systems Strengthening, and President
Obama’s Global Health Initiative are evidence of the growing
momentum in favour of health system strengthening. At the same
time, there is also an increased emphasis on health systems
research. During the last attempt at malaria eradication,
research, including health systems research, was neglected
because it was assumed that rapid, uniform spraying operations
would lead to eradication. More recent successful malaria disease
and control programmes have been notable for including
research as a critical element [2,11,16].
Health Systems Effectiveness
As an original approach to understanding health system
impediments to sustaining malaria interventions at coverage levels
sufficient to reduce malaria morbidity and mortality to very low
levels, and to achieve and maintain malaria-free status, we
introduce the concept of health systems effectiveness. We used
this concept and a framework for analyzing constraints to scale-up
(see below) as ‘‘stepping stones’’ during our development of a
health systems research and development agenda.
Malaria control and elimination depend in equal measure on
high-performance health systems that can deliver malaria inter-
ventions at high and equitable levels of quality and with effective
coverage. In this context, effective coverage goes beyond the usual
notion of population access to include provider compliant delivery,
patient adherence, and individual benefit from the intervention
[17]. Effective coverage requires the concerted strength of all the
health system building blocks. When effective coverage levels are
inadequate or inequitable, the reasons are nearly always
interacting failures across the building blocks. To pinpoint where
system interventions and strengthening will be effective and
efficient, programme managers need to be able to diagnose those
problems and their determinants and interactions.
Figure 2 provides a graphical representation of the systems
effectiveness framework and shows how an initially high
intervention efficacy translates into low effectiveness in the real
world because of system-specific issues of suboptimal interven-
tion access, inadequate programme targeting because of diag-
nostic shortcomings, incomplete provider compliance, and client
adherence.
District health system observatories are being established in
Burkina Faso, Ghana, Mozambique, and Tanzania to determine
their respective health systems’ effectiveness in delivering artemi-
sinin-based combination therapies (ACTs) [18], and research
projects are starting to use the health systems effectiveness
framework to analyze the determinants of coverage [19].
However, the results of these research projects have yet to be
translated into strategically targeted health system–strengthening
interventions and programme corrections.
A final stepping stone we used to develop the research agenda
outlined in this paper is the framework for analyzing constraints to
scale-up, developed for the Commission for Macroeconomics and
Health [20]. This framework illustrates how barriers to expanding
coverage of essential health services operate at all levels of the
health system, from communities and households, through to
cross-sectoral and sociopolitical levels, and thus suggests that
interventions to address these barriers may need to operate at
multiple levels.
Towards a Systems Research and Development
Agenda
The health systems research and development agenda that our
group has developed derives from the ideas and concepts discussed
above and proposes the creation of a set of tools for applying the
systems effectiveness framework for malaria elimination and
control in different health system settings. The agenda is organized
both across health system levels (community, facility, district,
national, regional/global, and intersectorial; more details of these
levels are given later) and health system building blocks (see Box 2),
but, importantly it also takes account of ‘‘country groupings.’’
These groupings are relevant to the phases defined in the GMAP
and we discuss them here in some detail before presenting our
research and development agenda in full.
Figure 2. Graphical representation of the systems effectiveness framework. How interventions lose traction in health systems: example of
artemisinin-based combination therapy (ACT) antimalarial treatment in Rufiji Demographic Surveillance Area Tanzania in 2006. Source: INDEPTH
INESS Project. Systems Effectiveness Module, Swiss Tropical and Public Health Institute with data from Ifakara Health Institute and US Centers for
Disease Control and Prevention based on [45–47]. Image credit: Fusio ´n Creativa.
doi:10.1371/journal.pmed.1000397.g002
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identify the most relevant health system research agendas for
individual countries.
Group 1 includes countries where most of the population lives
in areas where malaria elimination is considered impossible with
existing tools. Currently, most of these countries are scaling up
malaria-control efforts and some are entering the sustained control
phase. This group includes most countries of sub-Saharan Africa
and Papua New Guinea. In these countries, which have large
areas with very intense malaria transmission, it is generally
assumed that malaria elimination will only be possible though the
large-scale application of new tools, which are still to be developed.
Most likely such new tools will need to be applied in combination
with existing ones, and the health system requirements for the
effective delivery of these tools will probably be similar to those of
current malaria-control interventions. Therefore, although under-
taking systems research from the perspective of elimination is likely
to be unproductive in group 1 countries, addressing current health
system constraints on malaria control will almost certainly prove
crucial for any future elimination efforts.
Group 2 includes countries with focal malaria, where a large
part of the population lives in malaria-free areas, and where
research aimed at health system strengthening is likely to play a
crucial role in interrupting transmission in many of the existing
foci. Many of these countries have diverse and complex health
system challenges. This group includes most of the malaria-
endemic countries in South and Central America, middle South
Asia, and Southeast Asia. In sub-Saharan Africa, it includes
southern Africa, the Horn, and the northern part of Sudan. It
corresponds closely to the GMAP group designated as ‘‘control:
low contribution to global deaths’’ [9], but includes additional
countries such as Bangladesh, India, Indonesia, and Nepal.
Group 3 includes countries that are elimination ready. This
group is almost identical to the ‘‘pre-elimination and elimination’’
countries in the World Malaria Report [9] and includes Argentina,
Mexico, most of the countries of the Middle East and Central Asia,
Central China, and possibly Sri Lanka, Vanuatu, and the
Solomon Islands. In these countries, health system issues are
generally not a crucial impediment to elimination, not necessarily
because the health systems are exceptionally strong but often
because the country’s malaria problem has always been relatively
easy to tackle with existing technologies due to intrinsic biologic
(e.g., vectorial capacity or efficiency) or socioeconomic and
development (e.g., improved housing) factors. However, review
of the road to elimination in these countries with the identification
of crucial health system determinants could provide valuable
lessons, so international collaborations/global initiatives should
focus on learning from past experiences rather than undertaking
direct support or capacity strengthening.
This grouping of countries is intended to be specific to the
malaria eradication health systems research agenda. A compre-
hensive listing of countries by these groupings has been avoided
because many countries have areas belonging to more than one of
these categories; this heterogeneity by itself presents policy and
implementation challenges. Furthermore, the boundaries between
groups are imprecise, and some countries could move from one
group to another within few years.
What Goals and Needs Should the malERA Health
Systems Research and Development Agenda
Include?
From our discussions, we propose that the malERA health
systems research and development agenda should consider the
critical/transformational and conditional/situation goals and
needs described in detail in Table 1. Some of these goals and
needs are also partly covered in other papers in this series. For
example, the need for tools to reduce unacceptably and avoidably
low effective coverage of essential malaria interventions and
malaria surveillance is also partly covered by the Monitoring and
Evaluation and Surveillance malERA consultative group [21], the
need for decision support tools to remove policy decision
uncertainty for when to commit to transitioning from control to
elimination is also covered in part by the malERA Consultative
Groups on Modeling and Cross-Cutting Issues [22,23], and the
need for a tool to determine the kind and mix of integrated
interventions that are cost-effective in differing epidemiologic and
health system contexts is covered in part by the malERA
Consultative Group on Modeling [22].
What Research Questions Must Be Asked to
Satisfy Health Systems Needs and Goals?
The research questions that emerge from this above analysis are
presented in Table 2 in a matrix of health system levels and health
system building blocks. Below, we discuss these questions in
greater detail arranged by health system organizational level. As in
Table 2, when no country grouping is specified, the discussion
refers to both group 1 and group 2 countries.
Community Level
Past experience indicates that fixed health facilities cannot reach
all those in need, and that extending the reach of services is
essential to achieve universal and equitable coverage with
interventions for malaria and other diseases. Community health
workers (CHWs) and home management of fevers (which has been
well documented in Africa) offer possible approaches. Several
examples of CHW initiatives are emerging from countries as
varied as India, Sri Lanka, Ethiopia, and Uganda [24,25]. More
needs to be done to capture and share the experience gained from
these programmes, and to ensure that opportunities are taken to
evaluate the effectiveness of different approaches to designing and
implementing CHW programmes.
A range of community-level factors affects the ability of health
systems to reach the population effectively, particularly groups that
are located far from formal health facilities and/or are mobile.
Some of these factors reflect the conventional barriers to access—
financial, physical/geographic, and social [26], but a better
understanding is needed of how community-level factors influence
use in particular settings, and how they can be addressed in the
context of malaria-control and elimination measures.
In the past, some community health programmes failed because
they did not recognize the need to compensate CHWs for time
spent delivering services, and because they were not sufficiently
linked into and supported by the health systems’ ‘‘higher’’ levels
[27,28]. There is a rich literature on CHW systems that should be
exploited, but given rapid changes—such as the greatly improved
levels of education and the proliferation of private providers in
many areas—continued experimentation with different approach-
es is needed to sustain CHW performance and motivation,
including different forms of health facility support (for example,
supervision). Better ways of integrating CHWs’ results into health
information and surveillance systems and ensuring that they
receive information from these systems also need investigating.
Furthermore, as malaria transmission falls and countries enter the
elimination phase, it will become critical that malaria surveillance
systems improve their coverage to include data from whichever
services are used by people at risk [21]. Finally, diagnostic and
PLoS Medicine | www.plosmedicine.org 4 January 2011 | Volume 8 | Issue 1 | e1000397other tools for use at the community level that are implemented as
part of integrated strategies for managing illness, such as the
Integrated Management of Childhood Illness (IMCI) and
Integrated Management of Adult and Adolescent Illness (IMAI)
strategies, have the potential to create quantum leaps in service
and need to be adapted through research to the changing malaria
epidemiological context. Unfortunately, few, if any, of these
strategies are being systematically promoted in malaria risk areas
in category 2 countries.
Facility Level
The health facility is the main point of contact with the health
system for many people with fever, although private and informal
providers are also important in many settings. It is also the focal
point for collection, and ideally, use of data gathered through
routine health management information systems. Many health
systems face the challenge of ensuring that health workers are
present in health facilities, have the required training and
knowledge, are equipped with the relevant drugs and other
supplies, and are motivated to use these resources to provide high-
quality and responsive care that follows national policies and
standards.
New research is needed on how best to improve health worker
performance [29,30]. A range of potential policy interventions has
been suggested, including the traditional approaches of training
and supervision, performance-based pay, bottom-up approaches
using community accountability structures, and interventions
addressing the mindset of health workers [31]. Other than
training, the evidence about what works best and in what contexts
is very limited, and deserves urgent attention.
Critically, interventions to improve health worker performance
need to recognize the interconnectedness of the different health
system building blocks. The design of pay-for-performance
schemes, for example, involves questions of how best to govern
such arrangements and the role of the community in these
schemes, what the form and level of payments to health workers
Table 1. Categorization of the malERA health systems research goals and approaches.
Categories Goals/Problems Means/Approaches Cross-Cutting Stage of Elimination/Eradication
Critical/transformational Reduce unacceptable and
avoidably low effective
coverage of essential
malaria interventions.
Develop/validate toolkit
for owning, analyzing,
and responding to
system-level bottlenecks
in intervention delivery
and use.
Yes, drugs,
vaccines, vector
control, diagnostics.
Scaling-up, sustained control,
preelimination, and elimination.
Harness a community
of health systems
analysts into the
malaria elimination
community.
Assess other models of
global disease elimination
enterprises to develop an
optimal approach to an
appropriately widened
community.
Yes. Scaling-up, sustained control,
preelimination and elimination,
prevention of reintroduction
Understand how and
facilitate strengthening
of health systems by
disease-specific global
health initiatives in malaria.
Assist global health
initiatives to apply systems
science to guide health
system strengthening
investments.
Yes, concerns
all agendas.
Scaling-up, sustained control,
preelimination, and elimination.
Conditional/situational Facilitate policy decision
uncertainty for when to
commit to transitioning
from control to elimination
phase and understand
how disease-specific
global health investments
in malaria strengthen
health systems and
facilitate it.
Develop systems dynamic
modeling, tools and case
studies to understand
determinants for elimination
go-no/go policy decisions.
Yes, concerns
all agendas.
Scaling-up, sustained control and
preelimination, elimination.
Determine whether the
kind and mix of integrated
interventions are
cost-effective in differing
epidemiologic and
health system contexts.
Develop system dynamic
modeling and respective
tools as well as case studies
to assess synergies.
Yes, drugs, vaccines,
vector control.
Control, preelimination, elimination.
Increased emphasis Communicate determi-
nants of successful
regional and inter-
country collaboration
for disease elimination
Critical review and analysis. No. Elimination.
Major increase in community
and district engagement
and ownership of the
malaria-control and
elimination agenda.
Develop means to engage
communities more
effectively in case
management, vector
control, and surveillance.
Yes, drugs,
vaccines, vector
control, surveillance.
Control, preelimination, elimination.
doi:10.1371/journal.pmed.1000397.t001
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Level/Building
Block Governance Human Resources Financing Information
a
Service Delivery,
Medicines, and
Technology
Community level How can lay
boards (community leader
councils) strengthen local
health service delivery?
(Group 1 countries)
What is the role of
CHWs and private
sector providers in
treatment of malaria
and nonmalaria fevers,
and in what settings
are they crucial?
What are the
main financial
(and other) barriers
to health services
use and how can
these be overcome?
What is the best
approach to community-
based monitoring of
malaria and other
communicable diseases
building on existing
and past efforts?
How can the community
components of
integrated approaches
(IMCI and IMAI)
be strengthened and
adapted to different
epidemiological and
system settings?
What is the role of
communities in active
efforts at transmission
reduction (as opposed
to reducing morbidity
and mortality
from malaria)?
How can they be
incentivized and
integrated with the
health system to
support and sustain
their performance?
— How can health
information systems
include information
from and to CHWs?
(Group 1 countries)
—
Facility level Tools for assessing
illicit payment
for services
What are the most
effective and
appropriate methods
for monitoring health
worker performance?
— How can modeling
and evaluation
innovations for malaria
eradication strengthen
health systems?
Development of IMCI
and IMAI updated with
new diagnostic tools and
adapted to the malaria
elimination context
— What types of financial
and nonfinancial
incentives can best
support and sustain
improved health
worker performance?
— Tools for assessing
local coverage,
quality, and equity
to apply to systems
effectiveness
framework
Development of
appropriate multidisease
diagnostic tools
— — — — Tools for drugs and
supplies stock
management
District level What model(s) for
district manage-
ment of malaria-control
programmes are
effective in
achieving and maintai-
ning near zero malaria
burden en route
to elimination?
What are the
appropriate organiza-
tion and management,
skill mix, human
resource structure,
and enabling factors
to support effective
service delivery?
Tools for developing
efficient decentralized
decision making and
administration
How do we engage
private providers
and capture their
data?
How can private
provider involvement in
case management,
surveillance and
vector control be
harnessed?
— — — How can district
managers be
supported to use
the systems
effectiveness
framework and tools
to remove bottlenecks
in service delivery?
How can data for
decision-making skills be
taught such that
responses to
resurgences in malaria
burden are swiftly
responded to? [17]
Tools for systems
effectiveness framework
National level What investment
and tools will
ensure the quality
of governance
and accountability
required for
malaria elimination?
(Groups 2 and 3).
What experience is
there of strengthe-
ning health worker
motivation and
performance through
disease-specific
programmes, especially
looking at global
elimination initiatives
(positive synergies)?
What financial
resources will be
required to manage
the certification
process at subnational
and national levels?
(Groups 2 and 3).
What experience
is there of strengthe-
ning health
management information
systems through
disease-specific
programmes,
especially looking
at global elimination
initiatives (positive
synergies)?
What is the cost-
effectiveness of different
delivery modes in
different national/
subnational settings
(e.g., community
strategy versus facility,
integrated curative
services versus
specialized, integrated
vector management)
malaria vector
control; operations
research on effect of
scale
on optimal
organizational
structures?
PLoS Medicine | www.plosmedicine.org 6 January 2011 | Volume 8 | Issue 1 | e1000397should be, and the source of funding, how to use the health
information system to measure performance, how to ensure that
complementary inputs such as training and supplies are coordi-
nated and sustained, and how to avoid the risk that incentives may
distort targets and divert attention from nontargeted services.
Research on health worker performance should be multidisciplin-
ary, therefore, and needs to recognize the complexity of possible
interventions.
Research that focuses on developing new tools for assessing
coverage, quality, and equity at the facility level that can be used
to monitor health facility performance and analyze system
effectiveness is also needed. Such tools are essential to identify
Level/Building
Block Governance Human Resources Financing Information
a
Service Delivery,
Medicines, and
Technology
What governance
structures are
required to manage
the elimination
certification
process?
— What financing
mechanisms are
optimal at the
national level to
ensure a predictable
and sustained flow
of resources for
malaria elimination?
(Group 2)
— What experience is there
of strengthening service
delivery and logistics/
distribution chains
through disease-specific
programmes, especially
looking at global
elimination initiatives
(positive synergies)?
What experience is
there of strengthening
health system
governance through
disease-specific
programmes, especially
looking at global
elimination initiatives
(positive synergies).
—— ——
Tools to identify and
evaluate possible
interventions required
in health system
governance
—— ——
Regional and
global level
What are the
determinants
of successful
intercountry
collaboration on
shared public health
targets?
Tools: development
of better regional
training
— — What are the strengths
and weaknesses of
current malaria
surveillance and case-
management practices
in endemic countries
belonging to group 2?
Intersectoral
level
Does the formulation
of time-specific malaria
elimination targets
strengthen the
participation of
public and private
stakeholders?
— What are the
macroeconomic
benefits of malaria
elimination?
(Group 3)
— What are the local
geographic, economic,
ecological, cultural
determinants of malaria,
and community and
health system response?
Includes operations
research on service
provision for mobile and
marginalized
populations
— — — — What architecture and
dynamics of complex
intersectoral
intervention strategies
are required to achieve a
major, sustainable, and
cost-effective city-wide
impact on persistent
urban malaria?
Group 1, countries that are scaling up and entering the sustained control phase, where most of the population lives in areas where malaria elimination is considered
impossible with existing tools; group 2, countries with focal malaria, where a large part of the population lives in malaria-free areas, and where health systems
strengthening could play a crucial role in interrupting transmission in many but not necessarily all of the existing foci. These are often countries with very diverse and
complex health systems challenges; group 3, elimination-ready countries. When a group of countries is not indicated, the text applies to group 1 and group 2 countries
alike.
aResponsibility for these issues shared with malERA Monitoring, Evaluation, and Surveillance group.
IMAI, integrated management of adult and adolescent illness; IMCI, integrated management of childhood illness.
doi:10.1371/journal.pmed.1000397.t002
Table 2. Cont.
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context of malaria elimination activities, the development of
surveillance systems and the development of ways to monitor their
performance require highest attention.
In some settings, a significant amount of treatment seeking for
fever takes place outside public sector facilities, through private
health providers, pharmacies, and shops. The engagement of such
providers has mainly been done in limited malaria intervention
projects rather than in programmes, and most of the literature
concerns the pre-artemisinin-based combination therapy–rapid
diagnostic test (ACT-RDT) era [32]. More research is therefore
needed on approaches to quality assurance that will ensure that
these facilities/providers adhere to guidelines [33], and are
covered by systems for gathering surveillance data.
District Level
The district is the initial coordination hub for delivering services
andcommoditiestopeople(throughhealthfacilitiesandcommunity
programmes). The district is therefore the focal point for priority
setting, resource allocation, financial administration, supply chain
management, accountability for health worker performance,
engagement of the private sector, surveillance and response, and
monitoring, evaluation, and information management.
Some of the critical bottlenecks in malaria-control operations
currently stem from weaknesses at the district level for the above
operations. These bottlenecks result in inequitable or irrational
financial distribution, frequent stock-outs, poor-quality services,
and inefficient disease-control operations. The enhancement of
district-level system operations will therefore contribute signifi-
cantly to reducing effectiveness losses for interventions, and
increase the cost-effectiveness of programmes. Although there
has been substantial investment in district-strengthening ap-
proaches and tools, these have not been as productive as they
could be for a variety of reasons, such as insufficient decentral-
ization and lack of information feedback. Innovations in
information, communication, and decision-support tools (biomet-
rics, bar coding, mobile phones and texting, computerized logistics
systems, server-based data systems, among others) have the
potential to improve district health systems in a cost-effective
manner.
The systems challenges at the district level are common to group
1 and 2 countries. However, in group 1 countries they may be
almost universal in rural areas, whereas in group 2 countries,
systems challenges may only be considerable in the most malaria-
endemic areas where deep poverty, difficult terrain, and various
social barriers converge. Thus, district-strengthening efforts need
to be more targeted in group 2 than in group 1 countries.
Furthermore, in group 1 countries, the primary challenge is to
enable the health system to achieve universal coverage of malaria-
control interventions and to optimize their use (thereby reducing
effectiveness losses), whereas in group 2 countries and in group 1
countries where the malaria burden has decreased, the challenge
at the district level is increasingly to enable the system to respond
to the technical demands of elimination. This challenge requires a
greater focus on real-time information management and response
and so, in these settings, research data that is relevant to
developing decision-making skills will be critical.
National Level
Ultimately, the decision to embark on malaria elimination rests
at the national level even if malaria elimination applies to only a
region of the country. Such decisions must be based on operational
and technical feasibility, as well as regional economic and political
considerations [34].
Group 2 countries are more likely to have had some historical or
more recent regional experiences with malaria elimination, and
may see elimination as a ‘‘completeness exercise’’ or as an entry
point to strengthening the systems response to address the health
needs of neglected areas or population groups [35]. In some group
1 countries, elimination may be possible in specific areas.
Generally, elimination targets for provinces, regions, or other
administrative units that are highly developed and already close to
malaria-free status may be sensible and justified from a regional
viewpoint but of little importance from a national health
perspective (e.g., Zanzibar in Tanzania, Goa in India). By
contrast, national elimination targets—provided they are realis-
tic—may provide strategic leverage for improving health equity at
the national level.
The overriding research questions at the national level must be
directed towards defining the best possible arrangements for
governance, structural and functional organization between the
system and malaria-specific programmes, and must be directed
towards determining the implications of malaria elimination for
cross-border political dialogue and arrangements with neigh-
bouring countries. Models for financial sustainability also need to
be established. These issues will be relevant in group 1, 2, and 3
countries, and through all the phases of disease control,
elimination, certification, and prevention of reintroduction. An
analytical review of past elimination programmes for other
diseases—both successes and failures—with these questions in
mind would be helpful. A recently published review provides
useful information on interactions between global health
initiatives and country health systems [36], but there are obvious
differences between initiatives for reducing major disease burdens
and elimination activities, which aim at small burdens.
Regional/Global Level
WHO recently revised its guidelines on malaria elimination and
certification, emphasizing the need for regional intercountry
collaboration [37]. In recent years, cross-border collaboration
for malaria control has been inefficient in contrast to, for example,
collaboration on polio elimination. Therefore, experiences from
these successful intercountry collaborations and malaria-control
initiatives should be mapped to provide a better evidence base for
strengthening the intercountry collaboration needed to achieve
national elimination targets.
An issue that will and should be addressed is subnational
elimination. While any country is free to certify any area as
malaria-free, WHO needs data on the achievement and
maintenance of subnational areas of malaria elimination to
develop guidance so that countries are spared the embarrassment
of declaring an area malaria-free only to have transmission be
detected soon after.
In addition, the current malaria surveillance and case-
management practices of a sample of countries should be
investigated and mapped by health systems research groups that
are external to and independent of the malaria-control/elimina-
tion programme (see [21]).
Intersectoral Collaboration
The engagement of sectors other than health is sometimes but
not always important for malaria control and elimination. The
importance of intersectoral collaboration is determined by the
extent to which other sectors are responsible for causing a local
malaria problem through environmental change or population
movement, and by whether a particular sector, such as education,
plays a crucial role in achieving elimination. There is an extensive
literature on the influence of development projects on malaria
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planning (e.g., [39,40]). Serious difficulties can be expected where
population movements related to natural and man-made disasters
and conflict occur, in situations where ‘‘spontaneous’’ population
movements related to traditional economies (for example,
nomadism, transhumance) occur, and in urban areas where a
multitude of actors make it difficult to identify the most important
partners, where there is often less social cohesion, and where
indoor residual spraying is often not possible.
Situations such as these have proven resilient to malaria control
and elimination efforts over several decades. Mobile populations
that are exposed to malaria, especially in or near forested areas in
Latin America and South and Southeast Asia, often belong to
ethnic minority groups and are subjected to various political and
economic pressures. Interdisciplinary research (geographical,
ecological, economic, social) and trials of different service delivery
modes have proven useful in, for example, the Amazon, Thailand,
and Vietnam [41–43]. Such research is needed in many more
areas to validate for local adaptations of approaches in specific
settings.
Urban malaria is a specific problem on the Indian subcontinent
[44] where it needs to be investigated in all its dimensions from
entomology to basic human ecology, and from household and
industrial politics to local, municipal, and national level politics.
Concluding Remarks
In our discussions and in this article we have identified and
characterized the major health systems needs relevant to the
elimination of malaria and have articulated key research questions
that need to be addressed at various health systems levels. In Box
3, we present the summary of the research and development
agenda for health systems and operational research that resulted
from our discussions. With malaria elimination on the agenda, one
important, generic question needs to be addressed through health
systems research. To what extent does an explicit target of malaria
elimination motivate other sectors to participate in malaria
control? If research evidence shows that such an explicit target is
a potent motivator of other sectors, then ministries of health might
be more inclined to be highly vocal and explicit about elimination
targets and about the possible consequences of not meeting these
targets.
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